Related Experiment Video
Updated: Feb 4, 2026

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
Antihypertensive Therapy in the Acute Phase of Lacunar Infarcts
Guanghui Zhang1, Pin Meng1, Zhenwei Guo1
1Department of Neurology, The First People's Hospital of Lianyungang City, Lianyungang, Jiangsu, China (mainland).
Insights
Combination antihypertensive therapy, particularly with calcium channel blockers, ACE inhibitors/ARBs, and beta-blockers or diuretics, improves outcomes for acute lacunar infarct patients with hypertension. This approach is superior to single-drug treatments for managing blood pressure and neurological recovery.
Area of Science:
- Neurology
- Cardiology
- Pharmacology
Background:
- Optimal hypertension management during acute lacunar infarcts remains unclear in real-world settings.
- Lacunar infarcts and hypertension require timely and effective blood pressure control.
- Understanding the impact of different antihypertensive regimens is crucial for patient outcomes.
Purpose of the Study:
- To evaluate the effects of various blood pressure lowering regimens on neurological progression and clinical outcomes in patients with acute lacunar infarcts.
- To compare the efficacy of different antihypertensive monotherapies and combination therapies.
- To identify optimal medical strategies for managing hypertension in the acute phase of lacunar stroke.
Main Methods:
- A cohort of 411 patients with first-episode lacunar infarcts and hypertension within 24 hours of symptom onset were analyzed.
- Patients received one of six antihypertensive treatments: calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), β-blocker (β-B), or diuretic drug (DD), alone or in combination, for the first 7 days.
- Neurological progression was assessed using the National Institute of Health Stroke Scale (NIHSS), and clinical outcomes were evaluated with the modified Rankin Scale (mRS).
Main Results:
- Combination therapy including CCB, ACEI/ARB, and β-B showed the lowest risk of neurological deterioration (OR=0.48) and unfavorable outcomes (OR=0.50).
- Combination therapy with CCB, ACEI/ARB, and DD also demonstrated reduced risk of deterioration (OR=0.63) and unfavorable outcomes (OR=0.77) at 3 months.
- Logistic regression analysis indicated that combination therapies were associated with significantly better outcomes compared to monotherapy.
Conclusions:
- Rational blood pressure lowering is beneficial for functional outcomes in the acute phase of lacunar infarcts.
- Combination antihypertensive therapy is superior to monotherapy in improving clinical outcomes and reducing neurological progression.
- These findings support the use of specific combination regimens for managing hypertension in acute lacunar stroke.
Abstract:
BACKGROUND The optimal medical regimen for managing hypertension during acute phase of lacunar infarcts has not yet been clarified in real world setting. The aim of this study was to evaluate blood pressure lowering regimens on neurological progression and clinical outcomes during the acute phase of lacunar infarcts. MATERIAL AND METHODS For this study, 411 patients with first-episode lacunar infarcts and hypertension within 24 hours of symptom onset were included. All patients received antihypertension therapies, with different regimens, as well as routine medication during first 7 days after onset. There were 6 proposed antihypertensive treatments: calcium channel blockers (CCB), angiotensin-converting enzyme inhibitors (ACEI), angiotensin receptor blockers (ARB), β-blocker (β-B), and diuretic drug (DD) alone or in combination. Neurological progression was defined as worsening by ≥1 point in the National Institute of Health Stroke Scale (NIHSS) for motor function. The outcome was assessed using the modified Rankin Scale (mRS): favorable outcome (mRS of 0-1) or unfavorable outcome (mRS 2-5). RESULTS Logistic regression analysis showed that combination therapy with CCB, ACEI/ARB, and β-B exhibited the lowest risk of deterioration (OR=0.48, P=0.019) and unfavorable outcomes (OR=0.50, P=0.022). Similarly, combination therapy with CCB, ACEI/ARB, and DD exhibited lower risk of deterioration (OR=0.63, P=0.033) and unfavorable outcome (OR=0.77, P=0.042) at 3 months. CONCLUSIONS Rational blood pressure lowering was beneficial to the functional outcomes of patients during acute phase of lacunar infarcts, and combination therapy was better than mono-drug therapy.
Related Concept Videos
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Action of Diuretics
Phase Diagrams
Phase Transitions
Antihypertensive Drugs: Thiazide-Class Diuretics

